Tokyo, Japan

Hikaru Miyagi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hikaru Miyagi: Innovator in Protein Structural Analysis

Introduction

Hikaru Miyagi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of protein structural analysis, holding a total of 2 patents. His work focuses on developing methods that enhance the understanding of complex proteins, which are crucial for various scientific and medical applications.

Latest Patents

Miyagi's latest patents include innovative methods involving an anti-BRIL antibody. This invention aims to provide a method for efficient structural analysis of target proteins that have previously been challenging to analyze. The anti-BRIL antibody specifically binds to BRIL or a BRIL fusion protein, along with an antigen-binding fragment. The patent also covers a nucleic acid encoding the anti-BRIL antibody, a vector containing this nucleic acid, and an antibody-producing cell that contains the vector. Furthermore, it outlines methods for producing the antibody and utilizing it in protein structural analysis.

Career Highlights

Hikaru Miyagi is associated with Kyowa Kirin Co., Ltd., a company known for its commitment to innovation in biopharmaceuticals. His work at the company has been instrumental in advancing research in protein analysis, contributing to the development of new therapeutic strategies.

Collaborations

Miyagi collaborates with notable colleagues, including Michihiko Suzuki and Hidetsugu Asada. Their combined expertise fosters a collaborative environment that enhances the research and development of innovative solutions in the field.

Conclusion

Hikaru Miyagi's contributions to protein structural analysis through his patents and collaborative efforts highlight his role as a key innovator in the scientific community. His work continues to pave the way for advancements in understanding complex proteins, which is essential for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…